|
|
| |
|
|
|
|
 |
|
|
Asthma
COPD
or not COPD? (Hamlet is
not amused...)
Definition and Epidemiology
-
Asthma is a chronic inflammatory disorder of the
airways that involves many cells and cellular
elements.
-
The chronic inflammation causes an increase in
hyperresponsiveness.
-
This leads to recurrent episodes of wheezing,
coughing, and breathlessness particularly at night
or in the morning.
-
These episodes are usually associated with widespread
but variable airflow obstruction that is reversible
spontaneously or with treatment.
-
To repeat, if asthma becomes irreversible it goes
into the COPD category.
-
Asthma is extremely common. It is thought that ~5% of
the adult merican population have asthma (I am one of
them).
-
The majority of cases begin before the age of 25 (I
was diagnosed at the age of 5), but asthma can
develop at any age.
-
The prevalence of asthma worldwide has increased more
than 30% since the 1970s with the greatest increases
in the newly industrialized countries.
-
Asthma is found disproportionately in inner cities
much like our lovely Newark!
-
It
accounts for ~15 million outpatient visits to
physicians and yearly costs of more than $6 billion
dollars.
|
|
|
Clinical Manifestations and Asthma Diagnosis
-
Symptoms of asthma (symptoms are things a patient
complains of)
-
Wheezing
-
Intermittent dyspnea
-
Cough, especially at night
-
Exercise induced wheezing and dyspnea
-
Signs of asthma (signs are what we, as doctors,
observe during the physical exam)
-
Wheezing on auscultation
-
Wheezing is most commonly heard on expiration, but
can be heard during inspiration during severe
asthma attacks.
|
-
Physiologic Abnormalities
-
Variable airflow obstruction
-
Responsiveness to bronchodilators (this seems
somewhat backwards – you’ve got asthma because you
respond well to the drugs we use to treat it, but oh
well. I’m just the scribe…)
-
Increased airway responsiveness (hyperresponsiveness)
-
To
diagnose a patient with asthma:
-
There should be a history of periodic airflow
obstruction.
-
The patient may report feeling perfectly fine
now, but if they’ve had previous problems they
still have asthma.
-
It’s not a constant disease so the absence of
symptoms at any given time does not mean an
absence of disease.
-
Airflow obstruction is at least partly reversible.
-
An FEV1 < 80 or an FEV1/FVC ration of less than
65% is indicative of obstruction.
-
After given a short-acting inhaled β2 agonist, the
FEV1 should increase at least 12% and 200mL.
-
Again, kind of backwards to diagnose through
treatment…
-
All other alternative diagnoses must be excluded.
-
Apparently vocal cord dysfunction can cause some
impressive wheezing that has nothing to do with
asthma.
-
Other problems include, vascular rings that
surround airways, foreign bodies (particularly
common in children), and other pulmonary diseases.
-
Below is a table of what to do when considering
alternative diagnoses.
|
Patient has symptoms but spirometry is normal |
Assess diurnal variation of peak flow over 1 to 2
weeks.
Tests of bronchoprovocation (methacholine,
histamine, exercise) – this will provoke an attake |
|
Suspect infection, large airway lesions, heart
disease, or obstruction |
Chest x-ray |
|
Suspect co-existing COPD, restrictive ventilatory
defect or central airway obstruction |
Additional pulmonary function studies
Diffusing capacity test |
|
Suspect other factors contribute to asthma |
Allergy tests – skin or in vitro
Nasal examination
Gastroesophageal reflux assessment |
-
The unique inflammatory response of asthma isn’t quite
worth it’s own subsection so I’ll include it here.
-
Antigens activate mast cells and Th2 cells in the
lung which are responsible for the initial response
of the body through leukotrienes and histamine.
-
They also release cytokines that recruit eosinophils
which release even more inflammatory mediators and
are responsible for sustained inflammation during an
asthma attack.
Classification of Asthma Severity and Therapy
|
|
Days with Symptoms |
Nights with Symptoms |
PEF or FEV1 |
PEF Variability |
|
Step 4
Severe Persistent |
Continuous |
Frequent |
≤60% |
>30% |
|
Step 3
Moderate Persistent |
Daily |
≥5/month |
>60%->80% |
>30% |
|
Step 2
Mild Persistent |
3-6/week |
3-4/month |
≥80% |
20-30% |
|
Step 1
Mild Intermittent |
≤2/week |
≤2/month |
≥80% |
<20% |
Drug
treatments are tailored to the step diagnosis of the
patient
-
All patients are given quick relief, short-acting β2
agonists like albuterol.
-
Want to see an albuterol inhaler? Just ask me!
-
Long term control is reserved for step 2 or higher.
-
Included in this group is anti-inflammatory agents
like inhaled corticosteroids and long acting β2
agonists like salmeterol.
Back to the Respiratory System
Index
|
|
|
|
|
| |
|
Navigation:
MedSkool.Net Home
-
Circulatory -
Excretory -
Integumentary -
Respiratory
MedSkool.Net Sitemap
|
All Content provided on or through
MedSkool.Net (i) is provided for informational purposes only, (ii) is not a
substitute for professional medical advice, care, diagnosis or treatment,
and (iii) is not designed to promote or endorse any medical practice,
program or agenda or any medical tests, products or procedures. The Site
does not contain information about all diseases, nor does this Site contain
all information that may be relevant to a particular medical or health
condition. You should not use any Content for diagnosing or treating a
medical or health condition. You should carefully read all information
provided by the manufacturers of any products advertised or promoted on or
through the Site and displayed on or in the associated product packaging and
labels before purchasing and/or using such products. If you have or suspect
that you have a medical problem, you should contact your professional
healthcare provider through appropriate means. You agree that you will not
under any circumstances disregard any professional medical advice or delay
in seeking such advice in reliance on any Content provided on or through the
Site. Reliance on any such Content is solely at your own risk.
Full Disclaimer
Copyright ©
2006 www.MedSkool.Net - All Rights Reserved - Trademarks used
herein are property of their respective owners
|
|
|
|
|